CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
| Revenue (Most Recent Fiscal Year) | $4.53M |
| Net Income (Most Recent Fiscal Year) | $-4.74M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.44 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.89 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -106.31% |
| Net Margin (Trailing 12 Months) | -106.31% |
| Return on Equity (Trailing 12 Months) | -63.74% |
| Return on Assets (Trailing 12 Months) | -32.14% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.56 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.17 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.20 |
| Inventory Turnover (Trailing 12 Months) | 2.56 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.14 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NYSEMKT |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 3.26M |
| Free Float | 2.70M |
| Market Capitalization | $6.20M |
| Average Volume (Last 20 Days) | 0.06M |
| Beta (Past 60 Months) | 0.85 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 17.32% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |